Chapter 9: Biotechnology : Principles and Processes | Summary

Restriction enzymes, also called restriction endonucleases, act as 'molecular scissors.' They were first isolated in 1963 from E. coli; the first well-characterised enzyme was Hind II, which recognises a specific six-base-pair sequence. Today, over 900 restriction enzymes from more than 230 bacterial strains are known. They are named by a convention based on the genus, species, and strain of the source bacterium, e.g., EcoRI from Escherichia coli RY 13.

Each restriction endonuclease recognises a specific palindromic nucleotide sequence. It cuts the DNA a little away from the centre of the palindrome site, leaving overhanging single-stranded stretches called 'sticky ends.' These sticky ends form hydrogen bonds with complementary ends, facilitating ligation by DNA ligase. DNA fragments produced by restriction enzyme digestion can be separated by gel electrophoresis on agarose gel, visualised using ethidium bromide staining under UV light, and isolated by elution for use in recombinant DNA construction.

Vectors are DNA molecules capable of carrying foreign DNA into a host cell and enabling its replication. Common vectors include plasmids and bacteriophages. A suitable cloning vector must have: an origin of replication (ori) to allow autonomous replication; a selectable marker (e.g., antibiotic resistance genes) to distinguish transformants from non-transformants; and unique cloning sites (recognition sequences for restriction enzymes) to allow insertion of foreign DNA.

The vector pBR322 is a well-known E. coli cloning vector that contains two antibiotic resistance genes (ampR and tetR), multiple restriction sites, and an ori. Insertional inactivation is a technique where foreign DNA inserted within the β-galactosidase gene prevents blue colour formation in the presence of a chromogenic substrate, allowing recombinant colonies (white) to be distinguished from non-recombinant ones (blue). For plant cells, Agrobacterium tumifaciens Ti plasmid (disarmed) and for animal cells, retroviruses are used as vectors.

Since DNA is hydrophilic, it cannot pass through cell membranes on its own. Bacterial cells must be made 'competent' to take up DNA by treating them with divalent cations such as calcium ions, which increase the permeability of the cell wall. Recombinant DNA is then introduced by incubating cells with recombinant DNA on ice, followed by a brief heat shock at 42°C, and returning them to ice.

Alternative methods for introducing DNA into host cells include: micro-injection, where recombinant DNA is directly injected into the nucleus of an animal cell; biolistics (gene gun), where cells are bombarded with DNA-coated gold or tungsten microparticles; and disarmed pathogen vectors, which transfer recombinant DNA into the host upon infection.

Recombinant DNA technology involves a sequence of steps: isolation of DNA (using enzymes like lysozyme for bacteria, cellulase for plant cells, and chitinase for fungi); fragmentation of DNA by restriction endonucleases; isolation of the desired DNA fragment via gel electrophoresis; ligation of the fragment into a vector; transfer of recombinant DNA into a host cell; culturing host cells for large-scale production; and extraction and purification of the desired product.

PCR (Polymerase Chain Reaction) is a crucial tool for amplifying specific DNA sequences. Each PCR cycle involves three steps: denaturation of double-stranded DNA, primer annealing, and extension of primers by a thermostable DNA polymerase (Taq polymerase from Thermus aquaticus). Repeated cycles can amplify a segment to approximately one billion copies. The amplified fragment can then be ligated into a vector for cloning.

Bioreactors are vessels in which raw materials are biologically converted into specific products using microbial, plant, animal, or human cells. They provide optimal conditions—temperature, pH, substrate, salts, vitamins, and oxygen—for large-scale production (100–1000 litres). The most commonly used bioreactors are stirred-tank bioreactors (simple and sparged), which have agitator systems, oxygen delivery systems, foam control systems, temperature and pH control systems, and sampling ports.

Downstream processing refers to the series of processes after the biosynthetic stage, including separation, purification, formulation with suitable preservatives, clinical trials, and quality control testing. These steps are essential before a biotechnological product is ready for marketing. The downstream processing and quality control requirements vary from product to product.

Chapter 9 establishes the theoretical and technical foundation of modern biotechnology. The discovery of restriction enzymes, DNA ligase, and cloning vectors by scientists like Boyer and Cohen transformed biology into a precise engineering discipline. The step-by-step processes of isolating DNA, cutting it at specific sites, ligating it into vectors, transforming host cells, expressing foreign genes, and scaling up production in bioreactors represent the complete workflow of recombinant DNA technology.

For CBSE board examinations, this chapter is highly important as questions regularly appear on restriction enzymes and their naming, palindromic sequences and sticky ends, features of cloning vectors (especially pBR322), methods of making cells competent, PCR steps, insertional inactivation, and the role of bioreactors in downstream processing. A thorough understanding of these concepts, supported by labelled diagrams, is essential for scoring full marks in both short-answer and long-answer questions.